These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Key issues in the diagnosis and treatment of multiple sclerosis. An overview. O'Connor P; Neurology; 2002 Sep; 59(6 Suppl 3):S1-33. PubMed ID: 12448786 [No Abstract] [Full Text] [Related]
3. Mechanisms of action of interferons and glatiramer acetate in multiple sclerosis. Dhib-Jalbut S Neurology; 2002 Apr; 58(8 Suppl 4):S3-9. PubMed ID: 11971121 [TBL] [Abstract][Full Text] [Related]
4. [Possibilities and limits of immunotherapy in multiple sclerosis. Inflammatory and degenerative aspects of the disease require a new pathogenetic concept]. Kornhuber ME; Zierz S Nervenarzt; 2003 Jun; 74(6):537-8; discussion 539. PubMed ID: 12799792 [No Abstract] [Full Text] [Related]
5. To treat, or not to treat: the therapeutic dilemma of idiopathic monosymptomatic demyelinating syndromes. Frohman EM; Racke M; van Den Noort S Arch Neurol; 2000 Jul; 57(7):930-2. PubMed ID: 10891973 [No Abstract] [Full Text] [Related]
7. What is new in the treatment of multiple sclerosis? Weinstock-Guttman B; Jacobs LD Drugs; 2000 Mar; 59(3):401-10. PubMed ID: 10776827 [TBL] [Abstract][Full Text] [Related]
8. Treatment with disease-modifying drugs for people with a first clinical attack suggestive of multiple sclerosis. Filippini G; Del Giovane C; Clerico M; Beiki O; Mattoscio M; Piazza F; Fredrikson S; Tramacere I; Scalfari A; Salanti G Cochrane Database Syst Rev; 2017 Apr; 4(4):CD012200. PubMed ID: 28440858 [TBL] [Abstract][Full Text] [Related]
9. [Pathogenesis and treatment of multiple sclerosis (state of the art in 2000)]. Zavalishin IA; Zhuchenko TD; Peresedova AV Vestn Ross Akad Med Nauk; 2001; (7):18-22. PubMed ID: 11523422 [TBL] [Abstract][Full Text] [Related]
11. [Recommendations for the use of immunomodulatory drugs in multiple sclerosis: the BCTRIMS consensus] [Brazilian Committee for Treatment and Research in Multiple Sclerosis]. Tilbery CP; Moreira MA; Mendes MF; Lana-Peixoto MA Arq Neuropsiquiatr; 2000 Sep; 58(3A):769-76. PubMed ID: 10973126 [TBL] [Abstract][Full Text] [Related]
12. [Multiple sclerosis (MS), an inflammatory or degenerative disease?]. Confavreux C; Vukusic S Presse Med; 2004 Feb; 33(3):151-2. PubMed ID: 15029024 [No Abstract] [Full Text] [Related]
13. Disease modifying treatment in multiple sclerosis. Fuller GN; Bone I J Neurol Neurosurg Psychiatry; 2001 Dec; 71 Suppl 2(Suppl 2):ii20-1. PubMed ID: 11701780 [No Abstract] [Full Text] [Related]
14. Interferon beta-1a for early multiple sclerosis: CHAMPS trial subgroup analyses. Beck RW; Chandler DL; Cole SR; Simon JH; Jacobs LD; Kinkel RP; Selhorst JB; Rose JW; Cooper JA; Rice G; Murray TJ; Sandrock AW Ann Neurol; 2002 Apr; 51(4):481-90. PubMed ID: 11921054 [TBL] [Abstract][Full Text] [Related]